tiprankstipranks
Trending News
More News >
Quanterix Corporation (QTRX)
NASDAQ:QTRX
US Market
Advertisement

Quanterix (QTRX) Earnings Dates, Call Summary & Reports

Compare
373 Followers

Earnings Data

Report Date
Mar 03, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.45
Last Year’s EPS
-0.3
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 10, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflected a strong execution in revenue growth and successful integration of Akoya, contributing to a positive cash position and early momentum in diagnostics. However, challenges remain due to declines in core Simoa revenue and weaknesses in U.S. academic and pharmaceutical markets, compounded by the ongoing government shutdown. Despite these challenges, the company is positioned well for future growth with early commercial and cross-selling momentum.
Company Guidance
In the Quanterix Corporation Q3 2025 earnings call, the company reported significant financial and operational achievements, emphasizing key metrics and strategic initiatives. Revenue for Q3 was $40.2 million, marking a 12% increase year-over-year. The integration of Akoya has been a focal point, with $67 million of the $85 million in targeted cost synergies already realized. The company invested $27 million in R&D year-to-date, about 30% of their revenue, highlighting their commitment to innovation in areas like Alzheimer's diagnostics. Quanterix is on track to end the year with approximately $120 million in cash and no debt, aiming for cash flow breakeven in 2026. The diagnostics segment generated $2.4 million in revenue for the quarter, with the LucentAD test potentially receiving a final pricing approval of $897. Quanterix continues to see commercial momentum with early cross-selling opportunities between the Simoa and Spatial portfolios, despite an uneven broader industry demand.
Revenue Growth and Integration Success
Delivered on revenue expectations with $40 million in Q3, marking a 12% year-over-year increase. Successfully integrated Akoya, realizing $67 million of the $85 million in targeted synergies.
Strong Cash Position
On track to finish the year with approximately $120 million in cash and no debt, supported by improved working capital and cost reductions from integration activities.
Early Success in Alzheimer's Diagnostics
Received a positive pricing recommendation for LucentAD test at $897. Added 4 diagnostics partners in Asia, expanding reach and availability of high sensitivity biomarker testing.
Early Commercial Momentum and Cross-Selling Opportunities
Significant early interest in combining tissue and blood insights, with noted cross-selling opportunities between Simoa and Spatial portfolios.

Quanterix (QTRX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

QTRX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 03, 2026
2025 (Q4)
-0.45 / -
-0.3
Nov 10, 2025
2025 (Q3)
-0.46 / -0.73
-0.219-233.33% (-0.51)
Aug 07, 2025
2025 (Q2)
-0.42 / -0.77
-0.25-208.00% (-0.52)
May 12, 2025
2025 (Q1)
-0.43 / -0.53
-0.26-103.85% (-0.27)
Mar 17, 2025
2024 (Q4)
-0.26 / -0.30
-0.339.09% (+0.03)
Nov 12, 2024
2024 (Q3)
-0.24 / -0.22
-0.21-4.29% (>-0.01)
Aug 08, 2024
2024 (Q2)
-0.27 / -0.25
-0.16-56.25% (-0.09)
May 07, 2024
2024 (Q1)
-0.31 / -0.26
-0.16-62.50% (-0.10)
Feb 29, 2024
2023 (Q4)
-0.31 / -0.33
-0.534.00% (+0.17)
Nov 06, 2023
2023 (Q3)
-0.37 / -0.21
-0.9577.89% (+0.74)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

QTRX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 10, 2025
$5.12$5.00-2.34%
Aug 07, 2025
$5.51$4.75-13.79%
May 12, 2025
$5.73$4.64-19.02%
Mar 17, 2025
$7.28$7.15-1.79%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quanterix Corporation (QTRX) report earnings?
Quanterix Corporation (QTRX) is schdueled to report earning on Mar 03, 2026, After Close (Confirmed).
    What is Quanterix Corporation (QTRX) earnings time?
    Quanterix Corporation (QTRX) earnings time is at Mar 03, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is QTRX EPS forecast?
          QTRX EPS forecast for the fiscal quarter 2025 (Q4) is -0.45.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis